197 related articles for article (PubMed ID: 24418799)
1. Exploring the decision to participate in the National Health Service Bowel Cancer Screening Programme.
Ekberg M; Callender M; Hamer H; Rogers S
Eur J Cancer Prev; 2014 Sep; 23(5):391-7. PubMed ID: 24418799
[TBL] [Abstract][Full Text] [Related]
2. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
[TBL] [Abstract][Full Text] [Related]
3. Inappropriate use of the faecal occult blood test outside of the National Health Service colorectal cancer screening programme.
Peacock O; Watts ES; Hanna N; Kerr K; Goddard AF; Lund JN
Eur J Gastroenterol Hepatol; 2012 Nov; 24(11):1270-5. PubMed ID: 22872076
[TBL] [Abstract][Full Text] [Related]
4. Concerns, perceived need and competing priorities: a qualitative exploration of decision-making and non-participation in a population-based flexible sigmoidoscopy screening programme to prevent colorectal cancer.
Hall N; Birt L; Rees CJ; Walter FM; Elliot S; Ritchie M; Weller D; Rubin G
BMJ Open; 2016 Nov; 6(11):e012304. PubMed ID: 27836872
[TBL] [Abstract][Full Text] [Related]
5. Exploring implications of Medicaid participation and wait times for colorectal screening on early detection efforts in Connecticut--a secret-shopper survey.
Patel VB; Nahar R; Murray B; Salner AL
Conn Med; 2013 Apr; 77(4):197-203. PubMed ID: 23691732
[TBL] [Abstract][Full Text] [Related]
6. What affects the uptake of screening for bowel cancer using a faecal occult blood test (FOBt): a qualitative study.
Chapple A; Ziebland S; Hewitson P; McPherson A
Soc Sci Med; 2008 Jun; 66(12):2425-35. PubMed ID: 18358581
[TBL] [Abstract][Full Text] [Related]
7. The NHS Bowel Cancer Screening Programme--a realistic approach with additional benefits.
West NJ; Poullis AP; Leicester RJ
Colorectal Dis; 2008 Sep; 10(7):708-14. PubMed ID: 17956587
[TBL] [Abstract][Full Text] [Related]
8. Exploratory study examining barriers to participation in colorectal cancer screening.
Paddison JS; Yip MJ
Aust J Rural Health; 2010 Feb; 18(1):11-5. PubMed ID: 20136809
[TBL] [Abstract][Full Text] [Related]
9. Predictors of repeat participation in the NHS bowel cancer screening programme.
Lo SH; Halloran S; Snowball J; Seaman H; Wardle J; von Wagner C
Br J Cancer; 2015 Jan; 112(1):199-206. PubMed ID: 25429524
[TBL] [Abstract][Full Text] [Related]
10. The National Health Service Bowel Cancer Screening Program: the early years.
Rees CJ; Bevan R
Expert Rev Gastroenterol Hepatol; 2013 Jul; 7(5):421-37. PubMed ID: 23899282
[TBL] [Abstract][Full Text] [Related]
11. Ambivalence and its influence on participation in screening for colorectal cancer.
Oster C; Zajac I; Flight I; Hart E; Young GP; Wilson C; Turnbull D
Qual Health Res; 2013 Sep; 23(9):1188-201. PubMed ID: 23917801
[TBL] [Abstract][Full Text] [Related]
12. Preferences for colorectal cancer screening techniques and intention to attend: a multi-criteria decision analysis.
Hummel JM; Steuten LG; Groothuis-Oudshoorn CJ; Mulder N; Ijzerman MJ
Appl Health Econ Health Policy; 2013 Oct; 11(5):499-507. PubMed ID: 23979875
[TBL] [Abstract][Full Text] [Related]
13. The effect of high quality assurance measures in bowel cancer screening on patient satisfaction of colonoscopy.
Sarkar S; Athwal V; Sturgess RP; Lythgoe D; Bodger K
J Gastrointestin Liver Dis; 2012 Sep; 21(3):251-8. PubMed ID: 23012665
[TBL] [Abstract][Full Text] [Related]
14. Beliefs about bowel cancer among the target group for the National Bowel Cancer Screening Program in Australia.
Jalleh G; Donovan RJ; Lin C; Slevin T; Clayforth C; Pratt IS; Ledger M
Aust N Z J Public Health; 2010 Apr; 34(2):187-92. PubMed ID: 23331364
[TBL] [Abstract][Full Text] [Related]
15. Screening for colorectal cancer: sense and sensibilities.
Van Hal G; Hoeck S; Van Roosbroeck S
Eur J Cancer; 2011 Sep; 47 Suppl 3():S156-63. PubMed ID: 21943969
[TBL] [Abstract][Full Text] [Related]
16. Modeling the decision to undergo colorectal cancer screening: insights on patient preventive decision making.
Wackerbarth SB; Peters JC; Haist SA
Med Care; 2008 Sep; 46(9 Suppl 1):S17-22. PubMed ID: 18725828
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer screening: Associations between information provision, attitudes and intended participation.
Brandhof SD; Fagerlin A; Hawley S; Toes-Zoutendijk E; Trevena L; McCaffery K; Korfage IJ
Patient Educ Couns; 2018 Mar; 101(3):546-550. PubMed ID: 28899711
[TBL] [Abstract][Full Text] [Related]
18. A retrospective observational study examining the characteristics and outcomes of tumours diagnosed within and without of the English NHS Bowel Cancer Screening Programme.
Morris EJ; Whitehouse LE; Farrell T; Nickerson C; Thomas JD; Quirke P; Rutter MD; Rees C; Finan PJ; Wilkinson JR; Patnick J
Br J Cancer; 2012 Aug; 107(5):757-64. PubMed ID: 22850549
[TBL] [Abstract][Full Text] [Related]
19. Emotional predictors of bowel screening: the avoidance-promoting role of fear, embarrassment, and disgust.
Reynolds LM; Bissett IP; Consedine NS
BMC Cancer; 2018 May; 18(1):518. PubMed ID: 29720112
[TBL] [Abstract][Full Text] [Related]
20. High yield of colorectal neoplasia detected by colonoscopy following a positive faecal occult blood test in the NHS Bowel Cancer Screening Programme.
Lee TJ; Clifford GM; Rajasekhar P; Rutter MD; Kometa S; Ritchie MC; Waddup G; Nylander D; McNally RJ; Rees CJ
J Med Screen; 2011; 18(2):82-6. PubMed ID: 21852700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
